Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-15

Clinical Trial Update: A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes [NA]

View source ↗

Summary

This document describes a randomized, double-blind, placebo-controlled trial evaluating biophoton therapy for Type 2 diabetes mellitus and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biophoton Therapy

Snippet

Sponsor: First Institute of All Medicines | Conditions: Type 2 Diabetes | NA | Status: RECRUITING